Aquaxis Law Office

M&A, Corporate, Commercial Transactions, Litigation and Dispute Resolution, Pharmaceuticals and Medical Devices

Partner

2024 November – present – I-ne Co., Ltd., Special Advisor
2023 July – present – Aquaxis Law Office
2020 – 2023 June – Sonderhoff & Einsel, Law and Patent Office
2017 – 2020 – Sojitz Corporation, Corporate Officer & COO, M&A Management Office and Controller’s Office
2018 – 2019 – LINE Corporation, Corporate Auditor
2011 – 2017 – K&L Gates Gaikokuho Joint Enterprise, Partner
2001 – 2011 – Clifford Chance Law Office, Partner
1991 – 2001 – Tanaka & Takahashi Law Officen, Attorney

Other Services

2017 – present – Global Health Innovative Technology Fund, Board Advisor
2016 – present – Keio Law School, Academic Advisory Board Member
2013 – present – Japan Pharmaceutical Industry Legal Affairs Association, International Affairs Working Group, Advisor
2010 – 2013 – Keio Law School, Lecturer
2010 – present – Tokyo Small-claim Court, Mediator
2010 – 2017 – Nihon L’Oreal K.K. Ethical Review Board Member
2008 – 2017 – Mundipharma Japan KK., Internal Clinical Trial Review Board, Member
2004 – present – Dai-ni Tokyo Bar Association, Arbitration Center, Arbitrator

Japanese and English

Dai-ni Tokyo Bar Association (1991)
Chartered Institute of Arbitration, Member (MCIArb)

1996 – Duke University School of Law (LL.M.)
1986 – Keio University (LL.B.)
―
Japan Corporate Governance Network, Director’s University, Master of Independent Director (MID)
Tokyo Medical and Dental University Interdisciplinary Life Science Consortium, Medical Innovation Talent Development Program (diploma)
Tsukuba Clinical Research & Development Organization (T-CReDO),　University of Tsukuba Graduate School of Comprehensive Human Science, Regulatory Science Program (diploma)